Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease that leads to progressive scarring (fibrosis) of lung tissue, making it harder to breathe. The exact cause remains unknown, but factors like aging, smoking, genetic predisposition, and environmental exposure may contribute to its development. Symptoms often start with a persistent dry cough, shortness of breath during activity, fatigue, and unintended weight loss. Over time, the disease worsens, leading to severe breathing difficulties and finger clubbing (widening of fingertips). While there is no cure, antifibrotic medications like Pirfenidone and Nintedanib can slow progression. Oxygen therapy, pulmonary rehabilitation, and lung transplants may help improve quality of life. Early diagnosis and medical intervention are crucial for managing IPF effectively.
